ArticleMolecules (Basel, Switzerland)2017

Methylisoindigo and Its Bromo-Derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in PDAC.

Jana Tegethoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.